Atlas Trials

SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT04676607 · COMPLETED

Trial details

NCT number
NCT04676607
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2020-12-17
Primary completion
2023-06-12
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.